B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

UGT1A6

MOLECULAR TARGET

UDP glucuronosyltransferase family 1 member A6

UniProt: P19224NCBI Gene: 545782 compounds

UGT1A6 (UDP glucuronosyltransferase family 1 member A6) is targeted by 2 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting UGT1A6

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1diclofenac5.66285
2celastrol0.691

About UGT1A6 as a Drug Target

UGT1A6 (UDP glucuronosyltransferase family 1 member A6) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 2 compounds with documented UGT1A6 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

UGT1A6 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.